KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia

July 29, 2015

Source: Humanigen, Inc.

Released July 29, 2015

©2019 Humanigen, Inc.  All rights reserved